Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Bisphosphonates Market Status and Forecast (2016-2027)
  • 1.3.2 Global Bisphosphonates Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Bisphosphonates Supply by Company

• 2.1 Global Bisphosphonates Sales Volume by Company
• 2.2 Global Bisphosphonates Sales Value by Company
• 2.3 Global Bisphosphonates Price by Company
• 2.4 Bisphosphonates Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Bisphosphonates Market Status by Category

• 3.1 Bisphosphonates Category Introduction
  • 3.1.1 Alendronate
  • 3.1.2 Ibandronate
  • 3.1.3 Risedronate
  • 3.1.4 Zoledronic Acid
• 3.2 Global Bisphosphonates Market by Category
  • 3.2.1 Global Bisphosphonates Sales Volume by Category (2016-2021)
  • 3.2.2 Global Bisphosphonates Sales Value by Category (2016-2021)
  • 3.2.3 Global Bisphosphonates Price by Category (2016-2021)
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Bisphosphonates Market Status by End User/Segment

• 4.1 Bisphosphonates Segment by End User/Segment
  • 4.1.1 Metastatic Bone Cancers
  • 4.1.2 Systemic Metabolic Bone Diseases
• 4.2 Global Bisphosphonates Market by End User/Segment
  • 4.2.1 Global Bisphosphonates Sales Volume by End User/Segment (2016-2021)
  • 4.2.2 Global Bisphosphonates Sales Value by End User/Segment (2016-2021)
  • 4.2.3 Global Bisphosphonates Price by End User/Segment (2016-2021)
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Bisphosphonates Market Status by Region

• 5.1 Global Bisphosphonates Market by Region
  • 5.1.1 Global Bisphosphonates Sales Volume by Region
  • 5.1.2 Global Bisphosphonates Sales Value by Region
• 5.2 North America Bisphosphonates Market Status
• 5.3 Europe Bisphosphonates Market Status
• 5.4 Asia Pacific Bisphosphonates Market Status
• 5.5 Central & South America Bisphosphonates Market Status
• 5.6 Middle East & Africa Bisphosphonates Market Status

6 North America Bisphosphonates Market Status

• 6.1 North America Bisphosphonates Market by Country
  • 6.1.1 North America Bisphosphonates Sales Volume by Country (2016-2021)
  • 6.1.2 North America Bisphosphonates Sales Value by Country (2016-2021)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Bisphosphonates Market Status

• 7.1 Europe Bisphosphonates Market by Country
  • 7.1.1 Europe Bisphosphonates Sales Volume by Country (2016-2021)
  • 7.1.2 Europe Bisphosphonates Sales Value by Country (2016-2021)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Bisphosphonates Market Status

• 8.1 Asia Pacific Bisphosphonates Market by Country
  • 8.1.1 Asia Pacific Bisphosphonates Sales Volume by Country (2016-2021)
  • 8.1.2 Asia Pacific Bisphosphonates Sales Value by Country (2016-2021)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Bisphosphonates Market Status

• 9.1 Central & South America Bisphosphonates Market by Country
  • 9.1.1 Central & South America Bisphosphonates Sales Volume by Country (2016-2021)
  • 9.1.2 Central & South America Bisphosphonates Sales Value by Country (2016-2021)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Bisphosphonates Market Status

• 10.1 Middle East & Africa Bisphosphonates Market by Country
  • 10.1.1 Middle East & Africa Bisphosphonates Sales Volume by Country (2016-2021)
  • 10.1.2 Middle East & Africa Bisphosphonates Sales Value by Country (2016-2021)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Bisphosphonates Manufacturing Cost Analysis
• 11.5 Bisphosphonates Sales Channel and Distributors Analysis
  • 11.5.1 Bisphosphonates Sales Channel
  • 11.5.2 Bisphosphonates Distributors
• 11.6 Bisphosphonates Downstream Major Buyers

12 Global Bisphosphonates Market Forecast by Category and by End User/Segment

• 12.1 Global Bisphosphonates Sales Volume and Sales Value Forecast (2022-2027)
• 12.2 Global Bisphosphonates Forecast by Category
  • 12.2.1 Global Bisphosphonates Sales Volume Forecast by Category
  • 12.2.2 Global Bisphosphonates Sales Value Forecast by Category
  • 12.2.3 Global Bisphosphonates Price Forecast by Category
• 12.3 Global Bisphosphonates Forecast by End User/Segment
  • 12.3.1 Global Bisphosphonates Sales Volume Forecast by End User/Segment
  • 12.3.2 Global Bisphosphonates Sales Value Forecast by End User/Segment
  • 12.3.3 Global Bisphosphonates Price Forecast by End User/Segment

13 Global Bisphosphonates Market Forecast by Region/Country

• 13.1 Global Bisphosphonates Market Forecast by Region (2022-2027)
  • 13.1.1 Global Bisphosphonates Sales Volume Forecast by Region (2022-2027)
  • 13.1.2 Global Bisphosphonates Sales Value Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Teva
  • 14.1.1 Company Information
  • 14.1.2 Bisphosphonates Product Introduction
  • 14.1.3 Teva Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Tecoland
  • 14.2.1 Company Information
  • 14.2.2 Bisphosphonates Product Introduction
  • 14.2.3 Tecoland Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Taj Pharmaceuticals
  • 14.3.1 Company Information
  • 14.3.2 Bisphosphonates Product Introduction
  • 14.3.3 Taj Pharmaceuticals Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Scinopharm Taiwan
  • 14.4.1 Company Information
  • 14.4.2 Bisphosphonates Product Introduction
  • 14.4.3 Scinopharm Taiwan Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Sanofi
  • 14.5.1 Company Information
  • 14.5.2 Bisphosphonates Product Introduction
  • 14.5.3 Sanofi Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Roche
  • 14.6.1 Company Information
  • 14.6.2 Bisphosphonates Product Introduction
  • 14.6.3 Roche Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Pfizer
  • 14.7.1 Company Information
  • 14.7.2 Bisphosphonates Product Introduction
  • 14.7.3 Pfizer Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Novartis
  • 14.8.1 Company Information
  • 14.8.2 Bisphosphonates Product Introduction
  • 14.8.3 Novartis Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Natco Pharma
  • 14.9.1 Company Information
  • 14.9.2 Bisphosphonates Product Introduction
  • 14.9.3 Natco Pharma Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Mylan
  • 14.10.1 Company Information
  • 14.10.2 Bisphosphonates Product Introduction
  • 14.10.3 Mylan Bisphosphonates Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Merck
• 14.12 Lianyungang Runzhong Pharmaceutical
• 14.13 Hangzhou Longshine Bio-Tech
• 14.14 Emcure Pharma
• 14.15 Eli Lilly
• 14.16 Apotex Corp
• 14.17 Amgen

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Bisphosphonates market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Bisphosphonates market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Alendronate
Ibandronate
Risedronate
Zoledronic Acid

Segmented by End User/Segment
Metastatic Bone Cancers
Systemic Metabolic Bone Diseases

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Teva
Tecoland
Taj Pharmaceuticals
Scinopharm Taiwan
Sanofi
Roche
Pfizer
Novartis
Natco Pharma
Mylan
Merck
Lianyungang Runzhong Pharmaceutical
Hangzhou Longshine Bio-Tech
Emcure Pharma
Eli Lilly
Apotex Corp
Amgen